functional precision oncology for improved patient healthcare


2022-Jan We welcome M.Sc. Christer Anker Andreassen who is joining the team as product developer! Mr. Andreassen will help finalizing our platform for clinical studies. andreassen
2021-Dec Oncosyne finishes successful research collaboration with Dr. Teijo Pellinen at FIMM. The project was made possible through a generous grant from FORREGION-Oslo Aksershus/Norway Health Tech/The Research Council of Norway.
2021-Jun Oncosyne moves into OCCI’s shining laboratories. We are excited to become a part of this ambitious, dynamic growth environment. test


Oncosyne AS is developing a platform for clinical-grade in vitro diagnostic drug screening. The company was co-founded by Jarle Bruun (CEO) and Peter W. Eide (CTO) late 2020. We are based in the Oslo Cancer Cluster Incubator.

image showing co-founders
Peter W. Eide (left) and Jarle Bruun

By culturing patients' cancer cells and performing personalized drug screening against a broad array of approved drugs and combinations thereof we aim to provide an in vitro diagnostic test report to guide patient treatment based on measured, actual sensitives.


Feel free to leave us an email at , or make us a call at . We have offices and laboratories at Ullernchausséen 64, Oslo, Norway.